eye drop Archives - Insight Presented by Prime Creative Media Thu, 20 Jul 2023 20:55:37 +0000 en-US hourly 1 https://www.insightnews.com.au/wp-content/uploads/2024/02/cropped-Insight-favicon-32x32.png eye drop Archives - Insight 32 32 Low-dose atropine EIKANCE secures first myopia TGA approval https://www.insightnews.com.au/low-dose-atropine-eikance-secures-myopia-tga-approval/ Thu, 17 Mar 2022 23:40:17 +0000 https://www.insightnews.com.au/?p=26164
Eikance 0.01% atropine was approved by the TGA in September 2021.

The Therapeutic Goods Administration (TGA) has approved EIKANCE 0.01%, Australia’s first low-dose atropine eye drop for myopia progression in children and young teenagers. The eye drop therapy – withRead More

The post Low-dose atropine EIKANCE secures first myopia TGA approval appeared first on Insight.

]]>
Eikance 0.01% atropine was approved by the TGA in September 2021.
The Therapeutic Goods Administration (TGA) has approved EIKANCE 0.01%, Australia’s first low-dose atropine eye drop for myopia progression in children and young teenagers. The eye drop therapy – with
Read More

The post Low-dose atropine EIKANCE secures first myopia TGA approval appeared first on Insight.

]]> Prednefrin Forte supply to be reinstated in February 2022 https://www.insightnews.com.au/prednefrin-forte-supply-to-be-reinstated-in-february-2022/ Fri, 28 Jan 2022 02:30:41 +0000 https://www.insightnews.com.au/?p=25109 contaminated artificial tears
The evidence is sound that HA is a lubricant with desired properties and performance, Martin Robinson says.

The post Prednefrin Forte supply to be reinstated in February 2022 appeared first on Insight.

]]> contaminated artificial tears
The evidence is sound that HA is a lubricant with desired properties and performance, Martin Robinson says.
Allergan has confirmed Prednefrin Forte (prednisolone acetate and phenylephrine hydrochloride) eye drops (10mL) will be available once again across Australian pharmacies in February 2022. Due to manufacturing
Read More

The post Prednefrin Forte supply to be reinstated in February 2022 appeared first on Insight.

]]> FDA approves first presbyopia eye drop https://www.insightnews.com.au/fda-approves-first-presbyopia-eye-drop/ Mon, 01 Nov 2021 21:30:41 +0000 https://www.insightnews.com.au/?p=23520
Difficulty instilling eye drops and forgetfulness are common reasons for poor glaucoma treatment compliance.

The post FDA approves first presbyopia eye drop appeared first on Insight.

]]>
Difficulty instilling eye drops and forgetfulness are common reasons for poor glaucoma treatment compliance.
US regulators have approved the country’s first presbyopia eye drop that adopts pupil constriction to improve near and intermediate vision while maintaining some pupillary response to different lighting
Read More

The post FDA approves first presbyopia eye drop appeared first on Insight.

]]> Ikervis ciclosporin eye drop now PBS-listed https://www.insightnews.com.au/ikervis-ciclosporin-eye-drop-now-pbs-listed/ Thu, 30 Sep 2021 21:33:14 +0000 https://www.insightnews.com.au/?p=22895 Azura Ophthalmics meibomian gland dysfunction
Published six times per year, Contact Lens Update provides unbiased clinical insights based in current research.

The post Ikervis ciclosporin eye drop now PBS-listed appeared first on Insight.

]]> Azura Ophthalmics meibomian gland dysfunction
Published six times per year, Contact Lens Update provides unbiased clinical insights based in current research.
Pharmaceutical firm Seqirus has announced that its new therapy Ikervis is now available via the Pharmaceutical Benefits Scheme (PBS), making it Australia’s first listed disease modifying ciclosporin
Read More

The post Ikervis ciclosporin eye drop now PBS-listed appeared first on Insight.

]]> Complaints over compounded atropine eye drops in NSW https://www.insightnews.com.au/complaints-over-compounded-atropine-eye-drops-in-nsw/ Tue, 14 Sep 2021 21:47:05 +0000 https://www.insightnews.com.au/?p=22619
The FDA also cited quality issues related to product sterility.

The post Complaints over compounded atropine eye drops in NSW appeared first on Insight.

]]>
The FDA also cited quality issues related to product sterility.
The Pharmacy Council of New South Wales has reported a rise in complaints over compounded atropine eye drops, with one patient lodging their grievance with Ahpra after becoming aware the formulation was
Read More

The post Complaints over compounded atropine eye drops in NSW appeared first on Insight.

]]> NovaTears + Omega-3 effective against evaporative dry eye – study https://www.insightnews.com.au/novatears-omega-3-effectiveness-against-evaporative-dry-eye-study/ Mon, 02 Aug 2021 06:08:40 +0000 https://www.insightnews.com.au/?p=21868 NovaTears + Omega-3
NovaTears + Omega-3 was introduced in Australia and New Zealand last year.

The post NovaTears + Omega-3 effective against evaporative dry eye – study appeared first on Insight.

]]> NovaTears + Omega-3
NovaTears + Omega-3 was introduced in Australia and New Zealand last year.
Australasian drug company AFT Pharmaceuticals has announced results from a post-market study of licensed dry eye therapy NovaTears + Omega-3, stating it is a significantly effective treatment for the evaporative
Read More

The post NovaTears + Omega-3 effective against evaporative dry eye – study appeared first on Insight.

]]> Prednefrin Forte shortage – TGA approves alternative product https://www.insightnews.com.au/prednefrin-forte-shortage-tga-approves-alternative-product/ Tue, 01 Jun 2021 22:31:40 +0000 http://www.insightnews.com.au/?p=20605 Prednefrin Forte shortage eye drop
The company was alleged to manufacture eye drugs in multi-use bottles, without an adequate preservative.

The post Prednefrin Forte shortage – TGA approves alternative product appeared first on Insight.

]]> Prednefrin Forte shortage eye drop
The company was alleged to manufacture eye drugs in multi-use bottles, without an adequate preservative.
Allergan has secured regulatory approval for an alternative product to address a Prednefrin Forte shortage in Australia. The company confirmed to Insight it had received a Read More

The post Prednefrin Forte shortage – TGA approves alternative product appeared first on Insight.

]]> Presbyopia eye drop in final stage of clinical development https://www.insightnews.com.au/presbyopia-eye-drop-in-final-stage-of-clinical-development/ Tue, 12 Jan 2021 21:21:24 +0000 http://www.insightnews.com.au/?p=18554
The eye drops also prevented photoreceptors from deteriorating and preserved visual function over time.

The post Presbyopia eye drop in final stage of clinical development appeared first on Insight.

]]>
The eye drops also prevented photoreceptors from deteriorating and preserved visual function over time.
An ophthalmic pharmaceutical company has commenced two Phase 3 clinical studies to evaluate its eye drop candidate for presbyopia. Approximately 600 participants with presbyopia have enrolled in Orasis
Read More

The post Presbyopia eye drop in final stage of clinical development appeared first on Insight.

]]> Omega-3 dry eye drop arrives in Australia https://www.insightnews.com.au/dry-eye-omega-3-eye-drop-arrives-in-australia/ Mon, 16 Nov 2020 21:00:31 +0000 http://www.insightnews.com.au/?p=17792 NovaTears + Omega-3
NovaTears + Omega-3 was introduced in Australia and New Zealand last year.

The post Omega-3 dry eye drop arrives in Australia appeared first on Insight.

]]> NovaTears + Omega-3
NovaTears + Omega-3 was introduced in Australia and New Zealand last year.
AFT Pharmaceuticals has officially introduced NovaTears + Omega-3 eye drops in Australia, and provided new details about the formulation. Developed in Germany, the therapy is said to be a unique eye lubricant
Read More

The post Omega-3 dry eye drop arrives in Australia appeared first on Insight.

]]>